CRNX
Price
$57.15
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
14 days until earnings call
XENE
Price
$41.74
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
7 days until earnings call
Ad is loading...

CRNX vs XENE

Header iconCRNX vs XENE Comparison
Open Charts CRNX vs XENEBanner chart's image
Crinetics Pharmaceuticals
Price$57.15
Change-$0.00 (-0.00%)
Volume$545.03K
CapitalizationN/A
Xenon Pharmaceuticals
Price$41.74
Change-$0.00 (-0.00%)
Volume$416.34K
CapitalizationN/A
View a ticker or compare two or three
CRNX vs XENE Comparison Chart
Loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
XENE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
CRNX vs. XENE commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRNX is a StrongBuy and XENE is a Buy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (CRNX: $57.15 vs. XENE: $41.74)
Brand notoriety: CRNX and XENE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRNX: 72% vs. XENE: 73%
Market capitalization -- CRNX: $4.09B vs. XENE: $2.93B
CRNX [@Biotechnology] is valued at $4.09B. XENE’s [@Biotechnology] market capitalization is $2.93B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRNX’s FA Score shows that 1 FA rating(s) are green whileXENE’s FA Score has 2 green FA rating(s).

  • CRNX’s FA Score: 1 green, 4 red.
  • XENE’s FA Score: 2 green, 3 red.
According to our system of comparison, XENE is a better buy in the long-term than CRNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRNX’s TA Score shows that 6 TA indicator(s) are bullish while XENE’s TA Score has 5 bullish TA indicator(s).

  • CRNX’s TA Score: 6 bullish, 4 bearish.
  • XENE’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CRNX is a better buy in the short-term than XENE.

Price Growth

CRNX (@Biotechnology) experienced а -2.64% price change this week, while XENE (@Biotechnology) price change was -5.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

CRNX is expected to report earnings on Mar 18, 2025.

XENE is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($4.09B) has a higher market cap than XENE($2.93B). CRNX YTD gains are higher at: 60.624 vs. XENE (-9.379). XENE has higher annual earnings (EBITDA): -233.68M vs. CRNX (-276.18M). CRNX has more cash in the bank: 863M vs. XENE (722M). XENE has less debt than CRNX: XENE (10M) vs CRNX (53.3M). CRNX has higher revenues than XENE: CRNX (1.39M) vs XENE (0).
CRNXXENECRNX / XENE
Capitalization4.09B2.93B140%
EBITDA-276.18M-233.68M118%
Gain YTD60.624-9.379-646%
P/E RatioN/AN/A-
Revenue1.39M0-
Total Cash863M722M120%
Total Debt53.3M10M533%
FUNDAMENTALS RATINGS
CRNX vs XENE: Fundamental Ratings
CRNX
XENE
OUTLOOK RATING
1..100
2017
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
97
Overvalued
PROFIT vs RISK RATING
1..100
711
SMR RATING
1..100
9694
PRICE GROWTH RATING
1..100
3848
P/E GROWTH RATING
1..100
1007
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRNX's Valuation (90) in the Pharmaceuticals Major industry is in the same range as XENE (97) in the Biotechnology industry. This means that CRNX’s stock grew similarly to XENE’s over the last 12 months.

CRNX's Profit vs Risk Rating (7) in the Pharmaceuticals Major industry is in the same range as XENE (11) in the Biotechnology industry. This means that CRNX’s stock grew similarly to XENE’s over the last 12 months.

XENE's SMR Rating (94) in the Biotechnology industry is in the same range as CRNX (96) in the Pharmaceuticals Major industry. This means that XENE’s stock grew similarly to CRNX’s over the last 12 months.

CRNX's Price Growth Rating (38) in the Pharmaceuticals Major industry is in the same range as XENE (48) in the Biotechnology industry. This means that CRNX’s stock grew similarly to XENE’s over the last 12 months.

XENE's P/E Growth Rating (7) in the Biotechnology industry is significantly better than the same rating for CRNX (100) in the Pharmaceuticals Major industry. This means that XENE’s stock grew significantly faster than CRNX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRNXXENE
RSI
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 12 days ago
81%
Bullish Trend 12 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 7 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
XENE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with ARWR. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then ARWR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
-1.40%
ARWR - CRNX
46%
Loosely correlated
+0.40%
NTLA - CRNX
45%
Loosely correlated
+2.45%
RARE - CRNX
44%
Loosely correlated
-1.39%
ELVN - CRNX
44%
Loosely correlated
-0.52%
EDIT - CRNX
44%
Loosely correlated
+2.52%
More

XENE and

Correlation & Price change

A.I.dvisor indicates that over the last year, XENE has been loosely correlated with AXSM. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if XENE jumps, then AXSM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XENE
1D Price
Change %
XENE100%
+0.02%
AXSM - XENE
40%
Loosely correlated
+0.27%
PLRX - XENE
40%
Loosely correlated
+5.02%
RCKT - XENE
39%
Loosely correlated
+2.64%
SNPX - XENE
36%
Loosely correlated
+4.51%
CRNX - XENE
35%
Loosely correlated
-1.40%
More